These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 22560933

  • 1. Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry.
    Damen NL, Versteeg H, Boersma E, Serruys PW, van Geuns RJ, Denollet J, van Domburg RT, Pedersen SS.
    Int J Cardiol; 2013 Sep 10; 167(6):2496-501. PubMed ID: 22560933
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.
    Pedersen SS, Denollet J, Ong AT, Sonnenschein K, Erdman RA, Serruys PW, van Domburg RT.
    Eur J Cardiovasc Prev Rehabil; 2007 Feb 10; 14(1):135-40. PubMed ID: 17301639
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy.
    Pedersen SS, Lemos PA, van Vooren PR, Liu TK, Daemen J, Erdman RA, Smits PC, Serruys PW, van Domburg RT.
    J Am Coll Cardiol; 2004 Sep 01; 44(5):997-1001. PubMed ID: 15337209
    [Abstract] [Full Text] [Related]

  • 8. Clustering of psychosocial risk factors enhances the risk of depressive symptoms 12-months post percutaneous coronary intervention.
    Pedersen SS, Denollet J, van Gestel YR, Serruys PW, van Domburg RT.
    Eur J Cardiovasc Prev Rehabil; 2008 Apr 01; 15(2):203-9. PubMed ID: 18391649
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduced positive affect (anhedonia) predicts major clinical events following implantation of coronary-artery stents.
    Denollet J, Pedersen SS, Daemen J, de Jaegere P, Serruys PW, van Domburg RT.
    J Intern Med; 2008 Feb 01; 263(2):203-11. PubMed ID: 18069998
    [Abstract] [Full Text] [Related]

  • 11. Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries).
    Cheng JM, Onuma Y, Piazza N, Nuis RJ, Van Domburg RT, Serruys PW, Interventional Cardiologists of Thoraxcenter (2000-2009).
    Am J Cardiol; 2010 Nov 15; 106(10):1376-81. PubMed ID: 21059424
    [Abstract] [Full Text] [Related]

  • 12. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H.
    J Invasive Cardiol; 2006 Dec 15; 18(12):577-83. PubMed ID: 17197706
    [Abstract] [Full Text] [Related]

  • 13. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry.
    Ong AT, Serruys PW, Aoki J, Hoye A, van Mieghem CA, Rodriguez-Granillo GA, Valgimigli M, Sonnenschein K, Regar E, van der Ent M, de Jaegere PP, McFadden EP, Sianos G, van der Giessen WJ, de Feyter PJ, van Domburg RT.
    J Am Coll Cardiol; 2005 Apr 05; 45(7):1135-41. PubMed ID: 15808774
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C, Onuma Y, Magro M, de Boer S, Battes L, van Domburg RT, Boersma E, Serruys PW, Interventional Cardiologists of the Thoraxcenter (2000-2005).
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):41-9. PubMed ID: 20310019
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Daemen J, Gaspersz M, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P.
    J Invasive Cardiol; 2011 Aug 01; 23(8):336-41. PubMed ID: 21828397
    [Abstract] [Full Text] [Related]

  • 20. Impact of peripheral vascular disease on short- and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent era.
    Midwall S, Swaminathan RV, Charitakis K, Kim LK, Gordin J, Hriljac I, Minutello RM, Bergman G, Wong SC, Feldman DN.
    J Invasive Cardiol; 2013 Mar 01; 25(3):132-6. PubMed ID: 23468442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.